Regarding CAC, Wick et al. reported a shift from preferential STAT6 activation to STAT3 activation regarding non-cancerous and cancerous samples from IBD patients [133], respectively, suggesting that STAT6 might prevent malignant transformation or might be downregulated in a neoplastic environment. The gene discussed is STAT6; the disease is inflammatory bowel disease.